|
Lopez-Galvez R, Marin F, Rivera-Caravaca JM. Predicting heart failure in atrial fibrillation patients: What about using biomarkers? Am Heart J. 2022 Sep;251:32-34. doi: 10.1016/j.ahj.2022.05.007. Epub 2022 May 7. No abstract available. PubMed PMID: 35537504.
AÑO: 2022; IF: 4.8
|
35537504
|
Esteve-Pastor MA, Ruiz-Ortiz M, Muniz J, Roldan-Rabadan I, Otero D, Cequier A, Bertomeu-Martinez V, Badimon L, Anguita M, Lip GYH, Marin F. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry. Front Cardiovasc Med. 2022 May 2;9:856222. doi: 10.3389/fcvm.2022.856222. eCollection 2022. PubMed PMID: 35586656; PubMed Central PMCID: PMC9108173.
AÑO: 2022; IF: 3.6
|
|
Proietti M., Vitolo M., Harrison S.L., Lane D.A., Fauchier L., Marin F., Nabauer M., Potpara T.S., Dan G.A., Boriani G., Lip G.Y.H. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry. Clinical Research in Cardiology. January 2022. 111:70-84. 10.1007/s00392-021-01914-y
AÑO: 2022; IF: 5.0
|
|
Ding WY, Rivera-Caravaca JM, Fazio-Eynullayeva E, Underhill P, Gupta D, Marin F, Lip GYH. Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation. Clin Res Cardiol. 2022 Sep;111(9):1040-1047. doi: 10.1007/s00392-021-01983-z. Epub 2022 Jan 7. PubMed PMID: 34994832; PubMed Central PMCID: PMC9424138.
AÑO: 2022; IF: 5.0
|
|
Ding WY, Boriani G, Marin F, Blomstrom-Lundqvist C, Potpara TS, Fauchier L, Lip GYH; ESC-EHRA EORP AF Long-Term General Registry Investigators. Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry. Eur Heart J Cardiovasc Pharmacother. 2022 Jun 8;8(4):372-382. doi: 10.1093/ehjcvp/pvab076. PubMed PMID: 34665249.
AÑO: 2022; IF: 7.1
|